Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
Open Access
- 8 March 2023
- journal article
- research article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 13 (3) , e12230
Abstract
Background: The composition of venom extracts, cross‐reactive carbohydrate determinants (CCD) and the component‐resolved diagnostics (CRD) are important fields of investigation. IgE‐reactivity to CCD complicates the interpretation of IgE to Hymenoptera venoms, especially in patients with multiple‐positivity. We analyzed the clinical importance of CRD and CCD‐inhibition for selection of allergens for venom immunotherapy (VIT).Methods: In 71 patients, we measured specific IgE (sIgE) to honeybee venom (HBV), wasp venom (WV), hornet venom (HV), CCD, and recombinant allergens: phospholipase A2 (rApi m 1), hyaluronidase (rApi m 2), icarapin (rApi m 10), antigen 5 (rVes v 5), and phospholipase A1 (Immunoblot). In 29/71 HBV/WV/HV/CCD‐positive patients CCD‐inhibition was performed. According to CRD and CCD‐inhibition, we identified true sensitization and defined groups of multiple‐positive patients who needed CCD‐inhibition before starting VIT.Results: sIgE‐rApi m 1, sIgE‐rApi m 2, and sIgE‐rApi m 10 were detected in 65.7%, 68.4%, and 58%, respectively. In HBV allergic patients, CRD sensitivity was 86.8%. In WV allergic patients, sensitivity of sIgE‐rVes v 5 was 94%. True multiple‐sensitization was found in 44.8% of HBV/WV/HV/CCD‐positive patients after CCD‐inhibition. Patients with multiple venom‐ and CCD‐positivity had more frequent severe allergic reactions (p < 0.001). CCD‐inhibition was helpful in HBV/WV/HV/CCD‐positive patients who were negative to all tested recombinant honeybee allergens. Persistence of HBV‐positivity after CCD‐inhibition requires CRD to other honeybee recombinant allergens.Conclusion: CRD, using a profile of five most important recombinant allergens and CCD, has a high sensitivity for the diagnosis of venom allergy, especially in patients positive to several venom extracts. CRD and CCD‐inhibition are helpful to reveal the clinically relevant, true sensitization and improve the selection of venoms for long‐lasting VIT.Keywords
This publication has 46 references indexed in Scilit:
- Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimerMolecular Immunology, 2011
- Added value of IgE detection to rApi m 1 and rVes v 5 in patients with Hymenoptera venom allergyJournal of Allergy and Clinical Immunology, 2011
- AnaphylaxisJournal of Allergy and Clinical Immunology, 2010
- Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of α-1,3-core fucosylationMolecular Immunology, 2010
- Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species‐specific major allergens Api m1 and Ves v5Allergy, 2009
- Kreuzreagierende Kohlenhydratdeterminanten (cross-reactive carbohydrate determinants, CCD) und ihre Bedeutung für die AllergiediagnostikAllergologie select, 2008
- Affinity of IgE and IgG against cross-reactive carbohydrate determinants on plant and insect glycoproteinsJournal of Allergy and Clinical Immunology, 2008
- In vitro hymenoptera venom allergy diagnosis: improved by screening for cross‐reactive carbohydrate determinants and reciprocal inhibitionAllergy, 2006
- The N‐glycans of yellow jacket venom hyaluronidases and the protein sequence of its major isoform in Vespula vulgarisThe FEBS Journal, 2005
- Relationship of Serum Venom-Specific IgE Titers to Clinical Aspects of Stinging Insect AllergyInternational Archives of Allergy and Immunology, 1989